| ²é¿´: 609 | »Ø¸´: 0 | |||
lrj107hnÌú¸Ëľ³æ (ÖøÃûдÊÖ)
·È˼×-·ÊÁú
|
[½»Á÷]
¡¾×ªÌû¡¿ÔçÆÚ͸ÎöÓëÍíÆÚ͸Îö±È½ÏµÄËæ»ú¡¢¶ÔÕÕÊÔÑé
|
|
ÔçÆÚ͸ÎöÓëÍíÆÚ͸Îö±È½ÏµÄËæ»ú¡¢¶ÔÕÕÊÔÑé ÕªÒª ±³¾°: ÔÚÁÙ´²Êµ¼ùÖУ¬¶ÔÓÚCKD5ÆÚ²¡ÈË£¬Î¬³ÖÐÔ͸Îö¿ªÊ¼µÄʱ¼äÓÐÏ൱´óµÄ²»Í¬¹Ûµã£¬ÏÖÔÚµÄÇ÷ÊÆÊÇÔçÆô¶¯½øÐÐά³ÖÐÂ͸Îö¡£ÔÚ±¾Ñо¿£¬ÔÚ°Ä´óÀûÑǺÍÐÂÎ÷À¼ÓÐ32¸öÖÐÐĽøÐÐÁ˸ÃÑо¿¡£ÎÒÃÇ·ÖÎöÁËά³ÖÐÂ͸Îö¶ö¿ªÊ¼Ê±¼ä¶ÔCKD»¼ÕßÉú´æµÄÓ°Ïì¡£ ·½·¨: ÎÒÃÇËæ»ú·ÖÅäÁË¡Ý18ËêµÄ½øÕ¹ÐÔCKD»¼Õߣ¬ÇÒeGFRÔÚ10.0µ½15.0ml/min£¨Cockcroft-Gault ¹«Ê½¼ÆË㣩¡£µ±eGFRÔÚ10.0µ½14.0ml/minʱ£¨ÔçÆÚ£©Æô¶¯Í¸Îö£¬»òÕßeGFRÔÚ5.0µ½7.0£¨ÍíÆÚ£©½øÐÐ͸Îö¡£Óв¿·Ö»¼ÕßµÄÖ÷Òª½á¹ûÊÇËÀÍö¡£ ½á¹û: ÔÚ2000Äê7Ôµ½2008Äê11Ô£¬828Ãû³ÉÈË»¼Õߣ¨Æ½¾ùÄêÁä60.4ËꣻÄУº542Ãû£¬Å®286Ãû£»ÌÇÄò²¡£º355Ãû£©Í¨¹ýËæ»ú»¯£¬ÔÚÔçÆÚ͸Îö×飬ƽ¾ù͸ÎöÆô¶¯Ê±¼ä1.8Ô£¨95%CI£¬1.60¡ª¡ª2.23£©£¬ÍíÆÚ͸Îö×éΪ7.4Ô£¨95%CI£¬6.23¡ª¡ª8.27£©¡£ ÔÚÍíÆÚ͸Îö×飬ÓÐ75.9%µÄ»¼ÕßÒòΪ֢״µÄÔÒò£¬ÔÚeGFR´óÓÚ7.0ml/minʱÆô¶¯Í¸Îö¡£ÔÚÆ½¾ù3.59ÄêµÄËæ·ÃÖУ¬ÔÚÔçÆÚ͸Îö×éµÄ404Ãû»¼ÕßÖУ¬ÓÐ152ÃûËÀÍö(Õ¼37.6%)£»ÔÚÍíÆÚ͸Îö×é424Ãû»¼ÕßÖУ¬155Ãû»¼ÕßËÀÍö£¨Õ¼36.6%£©£¨ÔçÆÚÆô¶¯Í¸ÎöΣÏÕ±ÈÊÇ1.04£»95%CI£¬0.83¡ª¡ª1.30£»P=0.75£©¡£ÔÚ²»Á¼Ê¼þµÄ·¢ÉúÉÏ£¨°üÀ¨ÐÄѪ¹Üʼþ¡¢¸ÐȾ¡¢Í¸ÎöµÄ²¢·¢Ö¢)£¬Ã»ÓÐÃ÷ÏԵIJîÒì¡£ ½áÂÛ:ÔÚ±¾Ñо¿ÖУ¬ÔÚCKD5ÆÚ»¼Õߣ¬ÔçÆÚÆô¶¯Í¸ÎöÓ뻼ÕßµÄÉú´æºÍÁÙ´²½á¹ûµÄ¸ÄÉÆÎ޹ء£ ( £¨¸ÃÑо¿±»°Ä´óÀûÑÇºÍÆäËû¹ú¼ÒµÄ¹ú¼ÒÎÀÉúºÍÒ½ÁÆÑо¿Î¯Ô±»á×ÊÖú£©°Ä´óÀûÑÇ¡¢ÐÂÎ÷À¼ÁÙ´²ÊÔÑé×¢²á±àºÅ£º12609000266268¡£ A randomized, controlled trial of early versus late initiation of dialysis. Cooper BA, Branley P, Bulfone L, Collins JF, Craig JC, Fraenkel MB, Harris A, Johnson DW, Kesselhut J, Li JJ, Luxton G, Pilmore A, Tiller DJ, Harris DC, Pollock CA; IDEAL Study. Collaborators (59)Kerr P, Krum H, Pitt A, Dawborn J, Forbes A, McNeil J, Tonkin A, Cooper BA, Kesselhut J, Davis M, Pilmore A, Martin A, Helyar J, Dempster J, Bisscheroux P, Kesselhut J, Milne A, Prasad R, Bohte H, Parag V, Holloway T, Jenkins M, Menahem S, Fraenkel MB, Harris DC, Mantha M, McIver M, Gillies A, Fassett R, Mathew M, Suranyi M, Brown F, Gray NA, Wyndham R, Shannon G, Johnson DW, Russ G, Elias T, Healy H, Kirkland G, Jose M, Cooper BA, Pollock CA, Irish A, Hutchison B, Brown M, Langham R, May S, Chowdhury S, Swao J, Lonergan M, Collins JF, Walker R, Voss D, Panlilio N, Madhan K, Fisher M, Matheson P, Walker J. Department of Renal Medicine, Royal North Shore Hospital, Sydney Medical School, Sydney, Australia. bcooper@med.usyd.edu.au N Engl J Med. 2010 Aug 12;363(7):678-80. Abstract BACKGROUND: In clinical practice, there is considerable variation in the timing of the initiation of maintenance dialysis for patients with stage V chronic kidney disease, with a worldwide trend toward early initiation. In this study, conducted at 32 centers in Australia and New Zealand, we examined whether the timing of the initiation of maintenance dialysis influenced survival among patients with chronic kidney disease. METHODS: We randomly assigned patients 18 years of age or older with progressive chronic kidney disease and an estimated glomerular filtration rate (GFR) between 10.0 and 15.0 ml per minute per 1.73 m2 of body-surface area (calculated with the use of the Cockcroft-Gault equation) to planned initiation of dialysis when the estimated GFR was 10.0 to 14.0 ml per minute (early start) or when the estimated GFR was 5.0 to 7.0 ml per minute (late start). The primary outcome was death from any cause. RESULTS: Between July 2000 and November 2008, a total of 828 adults (mean age, 60.4 years; 542 men and 286 women; 355 with diabetes) underwent randomization, with a median time to the initiation of dialysis of 1.80 months (95% confidence interval [CI], 1.60 to 2.23) in the early-start group and 7.40 months (95% CI, 6.23 to 8.27) in the late-start group. A total of 75.9% of the patients in the late-start group initiated dialysis when the estimated GFR was above the target of 7.0 ml per minute, owing to the development of symptoms. During a median follow-up period of 3.59 years, 152 of 404 patients in the early-start group (37.6%) and 155 of 424 in the late-start group (36.6%) died (hazard ratio with early initiation, 1.04; 95% CI, 0.83 to 1.30; P=0.75). There was no significant difference between the groups in the frequency of adverse events (cardiovascular events, infections, or complications of dialysis). CONCLUSIONS: In this study, planned early initiation of dialysis in patients with stage V chronic kidney disease was not associated with an improvement in survival or clinical outcomes. (Funded by the National Health and Medical Research Council of Australia and others; Australian New Zealand Clinical Trials Registry number, 12609000266268.) |
» ²ÂÄãϲ»¶
ÉúÎïҽѧ¹¤³Ì¿¼ÑÐ312Çóµ÷¼Á£¨¿É¿ìËÙ½ø×飩
ÒѾÓÐ0È˻ظ´
Postdoc position at University of Houston
ÒѾÓÐ0È˻ظ´
ÃÚÄòϵͳÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ109È˻ظ´
CiteSpaceÎÄÏ×¹²±»ÒýµÃ³öµÄÊÇÏÞ¶¨Ê±¼ä¶Î֮ǰµÄÎÄÏ×£¬ºÏÀíÂð£¿
ÒѾÓÐ0È˻ظ´
Ó¢¹ú˹ÍúÎ÷´óѧÕÐÊÕCSCÒÔ¼°È«½±²©Ê¿Éú£¨»úе/²ÄÁÏ/Á¦Ñ§£©
ÒѾÓÐ26È˻ظ´
Ó¢¹ú˹ÍúÎ÷´óѧÕÐÊÕCSCÒÔ¼°È«½±²©Ê¿Éú£¨»úе/²ÄÁÏ/Á¦Ñ§/¹¤³Ì£©
ÒѾÓÐ25È˻ظ´
Ó¢¹ú²¼Àï˹Íдóѧ³ÏÕв©Ê¿ÉúºÍ²©Ê¿ºó(½üÆÚ¶à¸ö²©Ê¿½±Ñ§½ð£©
ÒѾÓÐ41È˻ظ´
Ó¢¹ú²¼Àï˹Íдóѧ³ÏÕв©Ê¿ºó£¬²©Ê¿Éú£¬ÁªºÏÅàÑøÑо¿Éú¼°·ÃÎÊѧÕß
ÒѾÓÐ22È˻ظ´
¹ú×ÔÈ»·´À¡Òâ¼ûÄÜÑ¡ÎÞ°ïÖúÂð
ÒѾÓÐ10È˻ظ´
Ó¢¹ú²¼Àï˹Íдóѧ³ÏÕв©Ê¿Éú£¬²©Ê¿ºóºÍÁªºÏÅàÑøÉú
ÒѾÓÐ18È˻ظ´

ÕÒµ½Ò»Ð©Ïà¹ØµÄ¾«»ªÌû×Ó£¬Ï£ÍûÓÐÓÃŶ~
×öDOXµÄ»ºÊÍʵÑéѡȡ½ØÁô·Ö×ÓÁ¿ÊǶàÉÙµÄ͸Îö´ü±È½ÏºÏÊʰ¡£¿
ÒѾÓÐ5È˻ظ´
͸Îöºóµ°°×³Áµí
ÒѾÓÐ18È˻ظ´
¹ØÓÚϸ°ûʵÑéÊÇ·ñ±ØÐëÒª³ýÑκ͵°°×ÖÊ͸ÎöµÄÎÊÌâ
ÒѾÓÐ11È˻ظ´
µ°°×¾Í¸Îö´ü͸Îöºó³öÏÖ»ë×Ç£¬¼±Çó¸ßÊÖ°ïæ~£¡
ÒѾÓÐ12È˻ظ´
ÁòËáï§Ìݶȷ¨Ö÷¶¯ÔØÒ©Í¸Îö³ýÈ¥ÁòËáï§Ê±£¬¶Ô͸ÎöÒºÓÐÒªÇóÂð
ÒѾÓÐ11È˻ظ´
͸Îö´ü ͸Îö»ØÊÕBACÎÄ¿âËùÐè´óƬ¶ÎDNAµÄÏêϸ²Ù×÷Á÷³Ì
ÒѾÓÐ6È˻ظ´
¡¾ÇóÖú¡¿Í¸Îö´üµÄʹÓ÷¶Î§
ÒѾÓÐ14È˻ظ´
¡¾ÇóÖú¡¿¼±Çó ͸Îö´ü͸ÎöС·Ö×ÓµÄÎÊÌâ
ÒѾÓÐ10È˻ظ´
¡¾ÇóÖú¡¿Í¸Îö·¨ÖƱ¸ÄÉÃ׿ÅÁ£
ÒѾÓÐ8È˻ظ´
¿ÆÑдÓСľ³æ¿ªÊ¼£¬ÈËÈËΪÎÒ£¬ÎÒΪÈËÈË













»Ø¸´´ËÂ¥
µã»÷ÕâÀïËÑË÷¸ü¶àÏà¹Ø×ÊÔ´